Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Recombinant Protein / Other Proteins

Recombinant Human MUC6 Protein, N-His

Catalog #:   YHJ10401 Specific References (50) DATASHEET
Applications: ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress
Expression system: E. coli
Accession: Q6W4X9
Protein length: Gln44-Ser246
Overview

Catalog No.

YHJ10401

Expression system

E. coli

Species

Homo sapiens (Human)

Protein length

Gln44-Ser246

Predicted molecular weight

24.58 kDa

Nature

Recombinant

Endotoxin level

Please contact with the lab for this information.

Purity

>90% as determined by SDS-PAGE.

Accession

Q6W4X9

Applications

ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress

Form

Lyophilized

Storage buffer

Lyophilized from a solution in PBS pH 7.4, 0.02% NLS, 1mM EDTA, 4% Trehalose, 1% Mannitol.

Reconstitution

Reconstitute in sterile water for a stock solution. A copy of datasheet will be provided with the products, please refer to it for details.

Shipping

In general, proteins are provided as lyophilized powder/frozen liquid. They are shipped out with dry ice/blue ice unless customers require otherwise.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.

Alternative Names

MUC-6, MUC6, Gastric mucin-6, Mucin-6

Data Image
  • SDS-PAGE
    SDS PAGE for recombinant Human MUC6 protein
References

STAT3 inhibition mitigates experimental autoimmune gastritis by restoring Th17/Treg immune balance., PMID:40471463

Clinicopathological features and mucin expression of early papillary gastric adenocarcinoma., PMID:40467732

Dual Role of NRF2 in Pancreatic Precursor Lesions., PMID:40407127

The importance of MUC6 immunohistochemistry staining in the histopathologic examination of Crohn's disease: can we enhance our diagnostic power?, PMID:40239438

Integrative investigation on the mechanisms of modified Zuojin pill (SQQT) in ameliorating gastric metaplasia., PMID:40113112

An emerging entity of gastric adenocarcinoma: clinicopathological features and differential diagnosis of gastric adenocarcinoma of fundic-gland type in 25 retrospective cases., PMID:40100386

Integrated Analysis of WES and scRNA-Seq Data Reveals the Genetic Basis of Immune Dysregulation in Unexplained Recurrent Pregnancy Loss., PMID:40066928

Associations of mucinous differentiation and mucin expression with immune cell infiltration and prognosis in colorectal adenocarcinoma., PMID:39966658

MUC2 expression modulates immune infiltration in colorectal cancer., PMID:39926604

Relationship between mucin gene polymorphisms and different types of gallbladder stones., PMID:39885433

Comprehensive histopathological analysis of gastric cancer in European and Latin America populations reveals differences in PDL1, HER2, p53 and MUC6 expression., PMID:39755998

Multi-omic biomarker panel in pancreatic cyst fluid and serum predicts patients at a high risk of pancreatic cancer development., PMID:39747972

Characterization of gastric/gastrointestinal-like immunophenotypes in endometrial endometrioid adenocarcinomas, including endometrioid adenocarcinomas with mucinous differentiation., PMID:39681262

Esophageal submucosal gland duct adenoma: An unrecognised esophageal counterpart of minor salivary gland tumours with frequent BRAF V600E mutations., PMID:39628355

Primary mucinous cystadenocarcinoma of the breast: A case report and literature review., PMID:39611063

Clinicopathologic and Genomic Features of Invasive Stratified Mucin-producing Carcinoma of the Uterine Cervix Coexisting With High-grade Squamous Intraepithelial Lesion., PMID:39475374

Molecular genetic analysis of colorectal carcinoma with an aggressive extraintestinal immunohistochemical phenotype., PMID:39333321

The Expression and Clinicopathological Significance of BRAF V600E and Mucin 6 in Intrahepatic Cholangiocarcinoma: A Retrospective Study., PMID:39246028

Genomic analysis reveals molecular characterization of CD30+ and CD30- extranodal natural killer/T-cell lymphomas (ENKTLs)., PMID:39187207

Variability in morphology and immunohistochemistry of Crohn's disease-associated small bowel neoplasms: implications of Claudin 18 and Cadherin 17 expression for tumor-targeted immunotherapies., PMID:39164422

[Serrated dysplasia of the gastric fundus with malignant transformation: report of a case]., PMID:39103277

Network and structural analysis of quail mucins with expression pattern of mucin 1 and mucin 4 in the intestines of the Iraqi common quail (Coturnix coturnix)., PMID:39077459

The utility of the lineage specific immunohistochemical stains SATB2, CDX2, and villin, and the mucin glycoproteins MUC2, MUC5AC, and MUC6 to distinguish pulmonary invasive mucinous adenocarcinoma from metastatic colorectal carcinoma., PMID:39029534

The Clinicopathological and Molecular Characteristics of Endocervical Gastric-Type Adenocarcinoma and the Use of Claudin18.2 as a Potential Therapeutic Target., PMID:39025403

B3GNT7 regulates mucin O-glycosylation to alleviate colonic inflammation., PMID:38886669

Gastric epithelial neoplasm of fundic-gland mucosa lineage: representative of the low atypia differentiated gastric tumor and Ki67 may help in their identification., PMID:38873175

[Primary mucinous gland lesions of fallopian tube: a clinicopathological analysis of fourteen cases]., PMID:38825898

Possible association of G6PC2 and MUC6 induced by low‑dose‑rate irradiation in mouse intestine with inflammatory bowel disease., PMID:38785154

Unveiling the characteristics of D4 and R4 aptamers for their future use in prostate cancer clinical practice., PMID:38763045

Unveiling the Genomic Landscape of Intraductal Carcinoma of the Prostate Using Spatial Gene Expression Analysis., PMID:38732035

A gastric invasive tubular adenocarcinomatous lesion arising from foveolar-type neoplasia: molecular histogenesis., PMID:38662253

Gastric Carcinoma in Autoimmune Gastritis: A Histopathologic and Molecular Study., PMID:38588886

Impaired Glycosylation of Gastric Mucins Drives Gastric Tumorigenesis and Serves as a Novel Therapeutic Target., PMID:38583723

[Clinicopathological and molecular genetic features of Crohn's disease]., PMID:38556818

CCL21 and CLDN11 Are Key Driving Factors of Lymph Node Metastasis in Gastric Cancer., PMID:38553809

Characterizing and forecasting neoantigens-resulting from MUC mutations in COAD., PMID:38539235

Altered glycosylation in secreting cells of the gastric glands of aquaporin-4-deficient mice., PMID:38533927

Hyper Mucinous Proliferations in the Mucosa of Patients with Inflammatory Bowel Disease: Histological Lesions with a Real Potential for Neoplastic Evolution?, PMID:38472971

Mucin phenotype and genetic alterations in non-V600E BRAF-mutated colorectal cancer., PMID:38423222

Heterogeneity of small duct- and large duct-type intrahepatic cholangiocarcinoma., PMID:38409827

A comparison analysis of the somatic mutations in early-onset gastric cancer and traditional gastric cancer., PMID:38253255

Changes in gene expression in the intestinal mucus of broilers with woody breast myopathy., PMID:38194832

Relationship Between Immunophenotypes, Genetic Profiles, and Clinicopathologic Characteristics in Small Bowel Adenocarcinoma., PMID:38062562

Decreased expression of TFF2 and decreased αGlcNAc glycosylation are malignant biomarkers of pyloric gland adenoma of the duodenum., PMID:38062108

Identification of differentially expressed genes associated with the pathogenesis of gastric cancer by bioinformatics analysis., PMID:38041130

Deep sequencing reveals recurrent somatic mutations and distinct molecular subgroups in gastric cancer in Mizo population, North East India., PMID:37967684

Licorice flavonoid alleviates gastric ulcers by producing changes in gut microbiota and promoting mucus cell regeneration., PMID:37952360

Genetic landscape and PD-L1 expression in Epstein-Barr virus-associated gastric cancer according to the histological pattern., PMID:37945587

Expression Profiling along the Murine Intestine: Different Mucosal Protection Systems and Alterations in Tff1-Deficient Animals., PMID:37628863

Stepwise progression of invasive mucinous adenocarcinoma based on radiological and biological characteristics., PMID:37619407

Datasheet
$ 313
Product specifications
100 μg 313 1 mg 1629

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Recombinant Human MUC6 Protein, N-His [YHJ10401]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only